Abivax S.A.(ABVX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABVX Abivax S.A.

休市中 11-22 16:00:00 EST

8.78

+0.08

+0.92%

盘后8.78

+0.000.00%

16:00 EST

最高9.08	最低8.64	成交量25.96万
今开8.69	昨收8.70	日振幅5.06%
总市值5.56亿	流通市值2.63亿	总股本6,328万
成交额229.94万	换手率0.87%	流通股本2,999万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":8.78,"timestamp":1732309200000,"preClose":8.7,"halted":0,"volume":259559,"hourTrading":{"tag":"盘后","latestPrice":8.78,"preClose":8.78,"latestTime":"16:00 EST","volume":21,"amount":184.38,"timestamp":1732309201422},"delay":0,"floatShares":29990944,"shares":63283222,"eps":-3.360326,"marketStatus":"休市中","marketStatusCode":7,"change":0.08,"latestTime":"11-22 16:00:00 EST","open":8.69,"high":9.08,"low":8.64,"amount":2299379.711846,"amplitude":0.050575,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.360326,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1697774400000,"adjPreClose":8.7,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":8.78,"preClose":8.78,"latestTime":"16:00 EST","volume":21,"amount":184.38,"timestamp":1732309201422},"volumeRatio":2.460279542755213},"requestUrl":"/m/hq/s/ABVX","defaultTab":"news","newsList":[{"id":"2484046546","title":"Abivax盘中异动 下午盘急速跳水5.47%报8.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484046546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484046546?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:02","pubTimestamp":1731952978,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时02分，Abivax股票出现波动，股价急速下跌5.47%。截至发稿，该股报8.98美元/股，成交量8.1094万股，换手率0.13%，振幅5.05%。Abivax股票所在的生物技术行业中，整体跌幅为0.11%。他们正在 3 期临床试验中评估其候选药物 obefazimod，此药物用于治疗患有中度至重度活动性溃疡性结肠炎的成人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119020258abcd06c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119020258abcd06c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2481590065","title":"Abivax盘中异动 股价大涨5.06%报10.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481590065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481590065?lang=zh_cn&edition=full","pubTime":"2024-11-05 04:40","pubTimestamp":1730752812,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日04时40分，Abivax股票出现波动，股价快速拉升5.06%。截至发稿，该股报10.79美元/股，成交量1.6953万股，换手率0.03%，振幅2.63%。Abivax股票所在的生物技术行业中，整体跌幅为0.51%。他们正在 3 期临床试验中评估其候选药物 obefazimod，此药物用于治疗患有中度至重度活动性溃疡性结肠炎的成人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110504401298e4059a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110504401298e4059a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2476262229","title":"Abivax盘中异动 股价大涨5.12%报9.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476262229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476262229?lang=zh_cn&edition=full","pubTime":"2024-10-17 02:38","pubTimestamp":1729103914,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日02时38分，Abivax股票出现波动，股价快速拉升5.12%。截至发稿，该股报9.97美元/股，成交量17.2009万股，换手率0.27%，振幅5.80%。Abivax股票所在的生物技术行业中，整体涨幅为0.00%。他们正在 3 期临床试验中评估其候选药物 obefazimod，此药物用于治疗患有中度至重度活动性溃疡性结肠炎的成人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101702383598e3cd6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101702383598e3cd6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2474407409","title":"Abivax盘中异动 急速跳水5.02%报9.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474407409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474407409?lang=zh_cn&edition=full","pubTime":"2024-10-09 02:59","pubTimestamp":1728413982,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日02时59分，Abivax股票出现异动，股价大幅下挫5.02%。截至发稿，该股报9.09美元/股，成交量2.4364万股，换手率0.04%，振幅5.12%。Abivax股票所在的生物技术行业中，整体涨幅为0.49%。他们正在 3 期临床试验中评估其候选药物 obefazimod，此药物用于治疗患有中度至重度活动性溃疡性结肠炎的成人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100902594298e3b3b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100902594298e3b3b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2473640159","title":"Abivax盘中异动 大幅跳水5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473640159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473640159?lang=zh_cn&edition=full","pubTime":"2024-10-05 00:05","pubTimestamp":1728057936,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日00时05分，Abivax股票出现异动，股价快速下跌5.54%。截至发稿，该股报9.72美元/股，成交量2.649万股，换手率0.04%，振幅3.69%。Abivax股票所在的生物技术行业中，整体跌幅为0.14%。他们正在 3 期临床试验中评估其候选药物 obefazimod，此药物用于治疗患有中度至重度活动性溃疡性结肠炎的成人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100500053698e3aa26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100500053698e3aa26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0},{"id":"2472581099","title":"Abivax盘中异动 临近收盘快速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472581099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472581099?lang=zh_cn&edition=full","pubTime":"2024-10-02 03:51","pubTimestamp":1727812284,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日03时51分，Abivax股票出现异动，股价急速下跌5.08%。截至发稿，该股报10.94美元/股，成交量22.2854万股，换手率0.35%，振幅3.21%。Abivax股票所在的生物技术行业中，整体涨幅为0.12%。Abivax公司简介：Abivax SA 是一家总部位于法国的临床阶段生物技术公司，专注于开发利用人体自然调节机制稳定慢性炎症性疾病患者免疫反应的疗法。他们正在 3 期临床试验中评估其候选药物 obefazimod，此药物用于治疗患有中度至重度活动性溃疡性结肠炎的成人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100203512498e3a086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100203512498e3a086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABVX","BK4139"],"gpt_icon":0},{"id":"2470422764","title":"Abivax盘中异动 急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470422764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470422764?lang=zh_cn&edition=full","pubTime":"2024-09-27 03:45","pubTimestamp":1727379929,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日03时45分，Abivax股票出现异动，股价快速拉升5.02%。截至发稿，该股报11.72美元/股，成交量1.1655万股，换手率0.02%，振幅2.55%。Abivax股票所在的生物技术行业中，整体跌幅为0.04%。他们正在 3 期临床试验中评估其候选药物 obefazimod，此药物用于治疗患有中度至重度活动性溃疡性结肠炎的成人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927034529ab663b8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927034529ab663b8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KTTA","ABVX"],"gpt_icon":0},{"id":"2470944690","title":"Abivax盘中异动 大幅拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470944690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470944690?lang=zh_cn&edition=full","pubTime":"2024-09-25 03:18","pubTimestamp":1727205499,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日03时18分，Abivax股票出现波动，股价快速上涨5.16%。截至发稿，该股报11.42美元/股，成交量15.087万股，换手率0.24%，振幅4.05%。Abivax股票所在的生物技术行业中，整体跌幅为0.54%。他们正在 3 期临床试验中评估其候选药物 obefazimod，此药物用于治疗患有中度至重度活动性溃疡性结肠炎的成人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925031820ab65af52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925031820ab65af52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABVX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abivax.com","stockEarnings":[{"period":"1week","weight":-0.0758},{"period":"1month","weight":-0.1459},{"period":"3month","weight":-0.2431},{"period":"6month","weight":-0.3665},{"period":"1year","weight":-0.1324},{"period":"ytd","weight":-0.1794}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Abivax Sa是一家于2013年12月4日根据法国法律注册成立。该公司是一家临床阶段的生物技术公司，专注于开发利用人体自然调节机制来调节慢性炎症性疾病患者免疫反应的疗法。该公司目前正在3期临床试验中评估主要候选药物奥贝法兹莫德，用于治疗成人中度至重度活动性溃疡性结肠炎。","exchange":"NASDAQ","name":"Abivax S.A.","nameEN":"Abivax S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abivax S.A.(ABVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Abivax S.A.(ABVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Abivax S.A.,ABVX,Abivax S.A.股票,Abivax S.A.股票老虎,Abivax S.A.股票老虎国际,Abivax S.A.行情,Abivax S.A.股票行情,Abivax S.A.股价,Abivax S.A.股市,Abivax S.A.股票价格,Abivax S.A.股票交易,Abivax S.A.股票购买,Abivax S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abivax S.A.(ABVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Abivax S.A.(ABVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}